Thanks Marvin - that is probably the most well written financial analysis I have read on HC in a long time - great reading for a Sunday morning.
If one of the key risks for CM8 is its debt, then I take the interest cover ratio as a reasonable proxy for that risk, and at 5.34x an interest bill of around 20% of earnings is pretty low risk.
If another key risk is the integration of Track, then only time will tell, however Track is already an established product with a demonstrated growth and trajectory.
As you explained so well, CM8 represents pretty good value at this price level. Does that mean the SP can't go lower? Well it did this week, and on the chart I see a 12 month low of 13.5 so I see that level as the downside risk chart-wise, but value-wise on the basis of your argument suggests the lower the SP the stronger the value case so buyers will step in more and more, thereby providing support against lower prices if it were to go that way in the short term.
Cheers, Sharks.
- Forums
- ASX - By Stock
- UNT
- What is it worth?
What is it worth?, page-7
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.003(23.1%) |
Mkt cap ! $17.12M |
Open | High | Low | Value | Volume |
1.4¢ | 1.6¢ | 1.4¢ | $76.56K | 5.178M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 896333 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 186000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 896333 | 0.015 |
6 | 1602085 | 0.014 |
14 | 2848118 | 0.013 |
12 | 4587249 | 0.012 |
13 | 2657594 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 828648 | 2 |
0.017 | 1648521 | 9 |
0.018 | 207679 | 2 |
0.019 | 1765336 | 3 |
0.020 | 608805 | 4 |
Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
Featured News
UNT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online